|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01276 HENGRUI PHARMA
Nominal 
72.000 -0.300 (-0.415%) Ranking Overview
Ranking based on 8 research report(s)
Average Ranking 2.38
|
Strong Buy (1)
0
|
Buy (2)
5
|
Hold (3)
3
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 100.00 RMB (cts) | |
| Net Profit | 6,336.53 RMB (MIL) | DPS | -- RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 8,652.00 | 134.50 | 27.30 | -- | 10,181.00 | 7,339.00 |
| 2026 | 9,927.00 | 151.10 | 30.20 | -- | 11,071.00 | 8,584.00 |
| 2027 | 11,560.00 | 178.50 | 33.50 | -- | 13,140.00 | 9,955.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 8,887.00 | 134.00 | -- | CITIC SEC | Buy | 111.00 | 28/08/2025 | |
| 2025 | 10,181.00 | 156.00 | 46.00 | UBS | Buy | 97.80 | 01/09/2025 | |
| 2025 | 7,339.00 | 110.00 | 28.67 | MACQUARIE | OutPerform | 92.00 | 20/08/2025 | |
| 2025 | 8,521.10 | 128.00 | 14.55 | MORGAN STANLEY | Overweight | 86.00 | 28/10/2025 | |
| 2025 | 8,790.00 | 138.00 | -- | NOMURA | Buy | 80.57 | 28/07/2025 | |
| 2025 | 8,689.00 | 135.90 | 27.30 | DAIWA | Hold | 79.50 | 28/10/2025 | |
| 2025 | 8,615.00 | 135.00 | -- | JP MORGAN | Neutral | 78.00 | 23/09/2025 | |
| 2025 | 7,462.00 | 112.60 | -- | BOCOM | Neutral | 69.50 | 28/10/2025 | |
| 2026 | 10,933.00 | 165.00 | -- | CITIC SEC | -- | -- | 28/08/2025 | |
| 2026 | 11,071.00 | 167.00 | 50.00 | UBS | -- | -- | 01/09/2025 | |
| 2026 | 8,584.00 | 130.00 | 35.84 | MACQUARIE | -- | -- | 20/08/2025 | |
| 2026 | 10,340.70 | 156.00 | 14.55 | MORGAN STANLEY | -- | -- | 28/10/2025 | |
| 2026 | 10,150.00 | 159.00 | -- | NOMURA | -- | -- | 28/07/2025 | |
| 2026 | 9,704.00 | 146.20 | 30.20 | DAIWA | -- | -- | 28/10/2025 | |
| 2026 | 9,317.00 | 146.00 | -- | JP MORGAN | -- | -- | 23/09/2025 | |
| 2026 | 8,735.00 | 131.90 | -- | BOCOM | -- | -- | 28/10/2025 | |
| 2027 | 13,140.00 | 198.00 | -- | CITIC SEC | -- | -- | 28/08/2025 | |
| 2027 | 12,971.00 | 195.00 | 59.00 | UBS | -- | -- | 01/09/2025 | |
| 2027 | 9,955.00 | 150.00 | 43.01 | MACQUARIE | -- | -- | 20/08/2025 | |
| 2027 | 12,036.30 | 181.00 | 14.55 | MORGAN STANLEY | -- | -- | 28/10/2025 | |
| 2027 | 11,924.00 | 187.00 | -- | NOMURA | -- | -- | 28/07/2025 | |
| 2027 | 10,694.00 | 161.10 | 33.50 | DAIWA | -- | -- | 28/10/2025 | |
| 2027 | 11,196.00 | 176.00 | -- | JP MORGAN | -- | -- | 23/09/2025 | |
| 2027 | 10,385.00 | 156.80 | -- | BOCOM | -- | -- | 28/10/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 06/11/2025 11:37 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |